Table 2. Adjusted risks associated with GD in the overall series, in patients without cirrhosis and without diabetes, at multivariate logistic regression analysis.
Patients All | Patients without cirrhosis | Patients without diabetes | ||||
Variables | OR adj | 95% CI | OR adj | 95% CI | OR adj | 95% CI |
Female gender | 1.44 | 1.07–1.92 | 1.44 | 1.06–1.47 | 1.30 | 0.96–1.85 |
Age (yrs) | 1.03 | 1.00–1.04 | 1.01 | 1.00–1.04 | 1.05 | 1.01–1.07 |
Overweight/obesity (BMI >25 kg/m2) | 1.05 | 0.73–1.48 | 0.95 | 0.67–1.30 | 1.01 | 0.84–1.09 |
Waist circumference (M >102, F >88 cm) | 1.00 | 0.96–1.34 | 1.00 | 0.97–1.03 | 0.98 | 0.93–1.03 |
Fasting glucose (mmol/L) | 1.15 | 1.00–1.35 | 1.18 | 1.00–1.10 | 1.06 | 0.98–1.03 |
Diabetes | 1.24 | 0.83–1.86 | 0.75 | 0.48–1.13 | – | – |
HOMA-IR | 1.18 | 0.82–1.74 | 1.03 | 0.96–1.10 | 1.02 | 0.83–1.87 |
ALT U/L | 0.98 | 0.97–0.99 | 0.98 | 0.97–0.99 | 0.99 | 0.98–1.00 |
AST/ALT | 1.15 | 0.80–2.70 | 1.69 | 0.73–3.84 | 0.33 | 0.6–1.07 |
Metabolic Syndrome | 1.16 | 0.84–1.59 | 1.09 | 0.81–1.49 | 1.2 | 0.89–1.78 |
NASH | 1.46 | 1.08–1.99 | 1.51 | 1.14–2.15 | 1.5 | 1.10–2.10 |
Each variable adjusted for the others in the table.